BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26172313)

  • 1. Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response.
    Qin M; Landriscina A; Rosen JM; Wei G; Kao S; Olcott W; Agak GW; Paz KB; Bonventre J; Clendaniel A; Harper S; Adler BL; Krausz AE; Friedman JM; Nosanchuk JD; Kim J; Friedman AJ
    J Invest Dermatol; 2015 Nov; 135(11):2723-2731. PubMed ID: 26172313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes.
    Qin M; Pirouz A; Kim MH; Krutzik SR; Garbán HJ; Kim J
    J Invest Dermatol; 2014 Feb; 134(2):381-388. PubMed ID: 23884315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo.
    Kistowska M; Gehrke S; Jankovic D; Kerl K; Fettelschoss A; Feldmeyer L; Fenini G; Kolios A; Navarini A; Ganceviciene R; Schauber J; Contassot E; French LE
    J Invest Dermatol; 2014 Mar; 134(3):677-685. PubMed ID: 24157462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lutein attenuates Propionibacterium acnes-induced inflammation by inhibiting pyroptosis of human keratinocyte cells via TLR4/NLRP3/Caspase-1 pathway.
    Chen Y; Yi S; Wang Q; Xiong H; Yuan J; Zhang Y; Yang L; Zhong G; Li X; Zhu T
    Int Immunopharmacol; 2023 Apr; 117():109937. PubMed ID: 37012890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
    Han R; Blencke HM; Cheng H; Li C
    Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes.
    Li ZJ; Choi DK; Sohn KC; Seo MS; Lee HE; Lee Y; Seo YJ; Lee YH; Shi G; Zouboulis CC; Kim CD; Lee JH; Im M
    J Invest Dermatol; 2014 Nov; 134(11):2747-2756. PubMed ID: 24820890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose-derived stem cells attenuate acne-related inflammation via suppression of NLRP3 inflammasome.
    Li X; Luo S; Chen X; Li S; Hao L; Yang D
    Stem Cell Res Ther; 2022 Jul; 13(1):334. PubMed ID: 35871079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bee venom against Propionibacterium acnes-induced inflammation in human keratinocytes and monocytes.
    Kim JY; Lee WR; Kim KH; An HJ; Chang YC; Han SM; Park YY; Pak SC; Park KK
    Int J Mol Med; 2015 Jun; 35(6):1651-6. PubMed ID: 25872535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris.
    Caillon F; O'Connell M; Eady EA; Jenkins GR; Cove JH; Layton AM; Mountford AP
    Br J Dermatol; 2010 Feb; 162(2):296-303. PubMed ID: 19796181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalin suppresses Propionibacterium acnes-induced skin inflammation by downregulating the NF-κB/MAPK signaling pathway and inhibiting activation of NLRP3 inflammasome.
    Fang F; Xie Z; Quan J; Wei X; Wang L; Yang L
    Braz J Med Biol Res; 2020; 53(12):e9949. PubMed ID: 33111746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.
    Vowels BR; Yang S; Leyden JJ
    Infect Immun; 1995 Aug; 63(8):3158-65. PubMed ID: 7542639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.
    Guo M; An F; Yu H; Wei X; Hong M; Lu Y
    Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into acne pathogenesis: propionibacterium acnes activates the inflammasome.
    Contassot E; French LE
    J Invest Dermatol; 2014 Feb; 134(2):310-313. PubMed ID: 24424454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell pyroptosis via NLRP3-dependent pathway.
    He D; Zhou M; Bai Z; Wen Y; Shen J; Hu Z
    Biochem Biophys Res Commun; 2020 Jun; 526(3):772-779. PubMed ID: 32265028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
    Ryu S; Han HM; Song PI; Armstrong CA; Park Y
    PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propionibacterium acnes activates caspase-1 in human neutrophils.
    Sahdo B; Särndahl E; Elgh F; Söderquist B
    APMIS; 2013 Jul; 121(7):652-63. PubMed ID: 23278288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
    Kim J
    Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propionibacterium acnes-Derived Extracellular Vesicles Promote Acne-Like Phenotypes in Human Epidermis.
    Choi EJ; Lee HG; Bae IH; Kim W; Park J; Lee TR; Cho EG
    J Invest Dermatol; 2018 Jun; 138(6):1371-1379. PubMed ID: 29409885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways.
    Grange PA; Raingeaud J; Calvez V; Dupin N
    J Dermatol Sci; 2009 Nov; 56(2):106-12. PubMed ID: 19726162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.